Nalaganje...
EPND-12. TYROSINE KINASE INHIBITORS AXITINIB, IMATINIB AND PAZOPANIB ARE SELECTIVELY POTENT IN EPENDYMOMA
Reproducibly effective chemotherapy has yet to be identified for ependymoma (EPN), partly due to a lack of models for preclinical drug screening. Treatment of EPN has therefore changed little over the last 40 years and is essentially limited to surgery and radiation. Recurrence risk is high, particu...
Shranjeno v:
izdano v: | Neuro Oncol |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Oxford University Press
2017
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475033/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.070 |
Oznake: |
Označite
Brez oznak, prvi označite!
|